RVMD

$0.00

(

+0.00%

)
Quote details

stock

Revolution Medicines Inc

NASDAQ | RVMD

44.54

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$8.19B

Market Cap

-

P/E Ratio

-4.52

EPS

$62.40

52 Week High

$29.17

52 Week Low

HEALTHCARE

Sector

RVMD Chart

Recent Chart
Price Action

RVMD Technicals

Tags:

RVMD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$592M
Total Revenue $0
Cost Of Revenue $592M
Costof Goods And Services Sold $592M
Operating Income -$690M
Selling General And Administrative $97M
Research And Development $592M
Operating Expenses $97M
Investment Income Net -
Net Interest Income $87M
Interest Income $87M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $12M
Income Before Tax -$601M
Income Tax Expense $753K
Interest And Debt Expense -
Net Income From Continuing Operations -$600M
Comprehensive Income Net Of Tax -
Ebit -$601M
Ebitda -$589M
Net Income -$600M

Revenue & Profitability

Earnings Performance

RVMD Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $2.6B
Total Current Assets $2.3B
Cash And Cash Equivalents At Carrying Value $543M
Cash And Short Term Investments $543M
Inventory -
Current Net Receivables $0
Total Non Current Assets $231M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $57M
Intangible Assets Excluding Goodwill $57M
Goodwill $15M
Investments -
Long Term Investments -
Short Term Investments $1.7B
Other Current Assets $38M
Other Non Current Assets -
Total Liabilities $293M
Total Current Liabilities $164M
Current Accounts Payable $54M
Deferred Revenue -
Current Debt -
Short Term Debt $13M
Total Non Current Liabilities $129M
Capital Lease Obligations $136M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $136M
Other Current Liabilities $97M
Other Non Current Liabilities $670K
Total Shareholder Equity $2.3B
Treasury Stock -
Retained Earnings -$1.7B
Common Stock $18K
Common Stock Shares Outstanding $168M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$557M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$43M
Capital Expenditures $10M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$554M
Cashflow From Financing $959M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$600M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$592M
Total Revenue $0
Cost Of Revenue $592M
Costof Goods And Services Sold $592M
Operating Income -$690M
Selling General And Administrative $97M
Research And Development $592M
Operating Expenses $97M
Investment Income Net -
Net Interest Income $87M
Interest Income $87M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $12M
Income Before Tax -$601M
Income Tax Expense $753K
Interest And Debt Expense -
Net Income From Continuing Operations -$600M
Comprehensive Income Net Of Tax -
Ebit -$601M
Ebitda -$589M
Net Income -$600M

RVMD News

RVMD Profile

Revolution Medicines Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Revolution Medicines, Inc. is a clinical-stage oncology company headquartered in Redwood City, California, specializing in the development of innovative therapies targeting RAS-addicted cancers. With a commitment to harnessing precision medicine, the company's pipeline includes novel treatments designed to inhibit previously deemed "undruggable" targets, positioning it at the forefront of cancer therapeutics. Revolution Medicines is dedicated to improving outcomes for patients through its robust research and strategic partnerships, making it a compelling prospect for investors seeking exposure to breakthrough cancer therapies.

ATCH
+87.36%
$1.62
CGBS
-39.47%
$0.03
INTC
+25.22%
$31.18
BITF
+5.53%
$3.05
DVLT
+31.33%
$0.45
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
LYFT
+13.12%
$22.84
SOUN
+2.92%
$15.12
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
RGTI
+9.94%
$21.99
TPIC
-45.91%
$0.12
F
+0.43%
$11.66
AXDX
-61.36%
$0.03
JOBY
-1.59%
$14.16
LYT
-16.77%
$0.09
LASE
+29.64%
$3.63
RR
+2.84%
$3.98
KDLY
-4.66%
$1.43
IONQ
+5.10%
$65.44
AVGO
-3.84%
$346.17
AMZN
-1.03%
$231.62
MULN
-6.96%
$0.06
NVDA
+1.77%
$173.30
WULF
+3.74%
$11.35
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
+9.40%
$0.08
ETHD
-1.52%
$3.22
TLRY
-2.45%
$1.19
SRM
+53.27%
$10.30
IREN
+3.97%
$37.90
SNAP
+5.61%
$8.43
CIFR
+7.55%
$12.38
RZLV
-3.26%
$7.11
CWD
+20.62%
$7.66
ETNB
+85.45%
$14.98
AMD
-3.21%
$154.04
PLUG
+0.03%
$2.00
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MRVL
+3.07%
$70.98
BABA
+2.44%
$166.17
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
BURU
-0.86%
$0.13
HBAN
+1.52%
$17.54
ORCL
-1.70%
$301.41
JBLU
0.00%
$5.07
ETWO
0.00%
$3.30
WMT
+0.82%
$104.27
HPE
+1.22%
$24.73
CRWV
+1.77%
$120.86
KDP
+1.11%
$27.26
AFMD
-34.94%
$0.18
YAAS
-4.19%
$0.06
PCG
+0.93%
$15.09
BMNR
+9.40%
$62.43
AMCR
-1.31%
$8.27
PBM
+32.79%
$4.94
NIO
-0.91%
$7.38
SLB
-1.27%
$34.79
BEEM
+15.01%
$2.91
BTBT
+2.36%
$3.03
SBET
+1.00%
$17.12
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CSCO
+1.18%
$67.72
EQX
-1.51%
$10.40
SQFT
+46.29%
$8.88
KVUE
+1.15%
$18.34
PLTR
+4.30%
$175.57
ASTI
+15.38%
$2.25
AUR
-2.80%
$5.89
BIAF
-30.03%
$0.18
TSLA
+0.50%
$427.99
BCDA
-29.31%
$1.08
BE
+8.70%
$79.67
ASST
-17.85%
$3.68
GIS
-0.76%
$49.18
QUBT
+5.47%
$18.67
IXHL
+3.78%
$0.54
SCHW
+1.16%
$92.09
NVNI
+29.17%
$1.04
AQB
+0.88%
$1.13
ZAPP
-46.30%
$0.15
UP
+6.31%
$2.19
QBTS
+0.02%
$22.54
XOM
+0.53%
$115.29
APVO
-6.00%
$1.41
USB
+2.52%
$49.61
RCAT
-10.20%
$10.11
VLY
+1.32%
$10.72
VTRS
+0.62%
$9.61
AEO
+0.05%
$19.88
VICI
-0.12%
$32.60
ATCH
+87.36%
$1.62
CGBS
-39.47%
$0.03
INTC
+25.22%
$31.18
BITF
+5.53%
$3.05
DVLT
+31.33%
$0.45
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
LYFT
+13.12%
$22.84
SOUN
+2.92%
$15.12
NEHC
-4.00%
$0.45
MARA
-1.08%
$17.34
RGTI
+9.94%
$21.99
TPIC
-45.91%
$0.12
F
+0.43%
$11.66
AXDX
-61.36%
$0.03
JOBY
-1.59%
$14.16
LYT
-16.77%
$0.09
LASE
+29.64%
$3.63
RR
+2.84%
$3.98
KDLY
-4.66%
$1.43
IONQ
+5.10%
$65.44
AVGO
-3.84%
$346.17
AMZN
-1.03%
$231.62
MULN
-6.96%
$0.06
NVDA
+1.77%
$173.30
WULF
+3.74%
$11.35
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
+9.40%
$0.08
ETHD
-1.52%
$3.22
TLRY
-2.45%
$1.19
SRM
+53.27%
$10.30
IREN
+3.97%
$37.90
SNAP
+5.61%
$8.43
CIFR
+7.55%
$12.38
RZLV
-3.26%
$7.11
CWD
+20.62%
$7.66
ETNB
+85.45%
$14.98
AMD
-3.21%
$154.04
PLUG
+0.03%
$2.00
BTE
-2.29%
$2.54
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
MRVL
+3.07%
$70.98
BABA
+2.44%
$166.17
WLGS
-5.57%
$0.04
RXRX
-2.68%
$4.71
BURU
-0.86%
$0.13
HBAN
+1.52%
$17.54
ORCL
-1.70%
$301.41
JBLU
0.00%
$5.07
ETWO
0.00%
$3.30
WMT
+0.82%
$104.27
HPE
+1.22%
$24.73
CRWV
+1.77%
$120.86
KDP
+1.11%
$27.26
AFMD
-34.94%
$0.18
YAAS
-4.19%
$0.06
PCG
+0.93%
$15.09
BMNR
+9.40%
$62.43
AMCR
-1.31%
$8.27
PBM
+32.79%
$4.94
NIO
-0.91%
$7.38
SLB
-1.27%
$34.79
BEEM
+15.01%
$2.91
BTBT
+2.36%
$3.03
SBET
+1.00%
$17.12
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
CSCO
+1.18%
$67.72
EQX
-1.51%
$10.40
SQFT
+46.29%
$8.88
KVUE
+1.15%
$18.34
PLTR
+4.30%
$175.57
ASTI
+15.38%
$2.25
AUR
-2.80%
$5.89
BIAF
-30.03%
$0.18
TSLA
+0.50%
$427.99
BCDA
-29.31%
$1.08
BE
+8.70%
$79.67
ASST
-17.85%
$3.68
GIS
-0.76%
$49.18
QUBT
+5.47%
$18.67
IXHL
+3.78%
$0.54
SCHW
+1.16%
$92.09
NVNI
+29.17%
$1.04
AQB
+0.88%
$1.13
ZAPP
-46.30%
$0.15
UP
+6.31%
$2.19
QBTS
+0.02%
$22.54
XOM
+0.53%
$115.29
APVO
-6.00%
$1.41
USB
+2.52%
$49.61
RCAT
-10.20%
$10.11
VLY
+1.32%
$10.72
VTRS
+0.62%
$9.61
AEO
+0.05%
$19.88
VICI
-0.12%
$32.60

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.